45,139 reports of this reaction
3.3% of all Enbrel reports
#4 most reported adverse reaction
ARTHRALGIA is the #4 most commonly reported adverse reaction for Enbrel, manufactured by Immunex Corporation. There are 45,139 FDA adverse event reports linking Enbrel to ARTHRALGIA. This represents approximately 3.3% of all 1,364,746 adverse event reports for this drug.
Patients taking Enbrel who experience arthralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHRALGIA is moderately reported among Enbrel users, representing a notable but not dominant share of adverse events.
In addition to arthralgia, the following adverse reactions have been reported for Enbrel:
The following drugs have also been linked to arthralgia in FDA adverse event reports:
ARTHRALGIA has been reported as an adverse event in 45,139 FDA reports for Enbrel. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHRALGIA accounts for approximately 3.3% of all adverse event reports for Enbrel, making it a notable side effect.
If you experience arthralgia while taking Enbrel, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.